morphimmune

Share Article

Hyper-targeted small molecules for reprogramming immune cells to treat disease
PI: Dr. Philip Low, Purdue University
Visit site

Share Article

Related Article

How Proprietary Data Analytics Is Used to Identify and Advance Translational Research at Scale

•

June 1, 2020

It’s People, Not Money, When Commercializing Academic Research

•

January 27, 2020

Successfully Navigating the Topography of University Commercialization

•

March 2, 2019